References
1 Timothy M, Cox T, Weinreb N, et al. Maintenance of Quality of Life in Adults with Type 1 Gaucher Disease Previously Stabilized on Enzyme Therapy Who Were Switched to Oral Eliglustat: 4 Year Results of the ENCORE Trial, Elsevier, Molecular Genetics and Metabolism, 62 Cox TM, Drelichman G, Cravo R, Balwani M, Burrow TA, Martins AM, et al. Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. Lancet. 2015;385(9985):2355-62
3 식품의약품안전처, 의약품/화장품 전자민원창구, 정보마당, 의약품등정보, 제품정보, 세레델가캡슐84밀리그램(엘리글루스타트)
4 Mistry PK, et al.Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial. JAMA. 2015;313(7):695-706.
5 EMA, Public summary of opinion on orphan designation
6 FDA News Release, FDA approves new drug to treat a form of Gaucher disease
7 보건복지부 제 2017-193호 <요양 급여의 적용기준 및 방법에 대한 세부사항(약제)> 고시 일부 개정 (엘리글루스타트)
8 유한욱 외, 리소좀 축적질환의 진단과 치료지침-고셔병, 고셔병에 대한 임상적 개괄, 2014
9 Cox TM, Drelichman G, Cravo R, Balwani M, Burrow TA, Martins AM, et al. Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy. Blood. 2017. doi: 10.1182/blood-2016-12-758409.
10 How I treat Gaucher Disease, Gaucher Clinic, Shaare Zedek Medical Center, Hebrew University–Hadassah Medical School, Jerusalem, Israel, The blood Journal, Volume 118, Issue 6, Ari Zimran
11 Sanofi Genzyme Internal Data, Gaucher Portfolio Strategy, Gaucher Portfolio Messaging Guide, Milestones in Gaucher Therapy.
13 Mistry PK. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among Hematologists-Oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007;82(8):697-701
14 Recommendation 16/09 : In the absence of other specific NICE or SMC guidance, the DHSS will make decisions on the use of any new orphan or ultra orphan drug/intervention following the principles and processes that are in place through the CRC. Dr P Emerson, December 2009 Available at: https://www.gov.im/media/631127/orphanorultraorphandruginterven.pdf